Lyfebulb Partners with UnitedHealth Group to Support Patient-Driven Innovations for People with Inflammatory Bowel Disease
January 17, 2018 08:00 ET
|
Lyfebulb
NEW YORK, Jan. 17, 2018 (GLOBE NEWSWIRE) -- Lyfebulb, a chronic disease-focused, patient-empowerment platform that connects patients, industry and investors to support user-driven innovation, is...
Regentys Names Dr. John F. Howes Vice President of Clinical and Regulatory Affairs
January 09, 2018 07:30 ET
|
Regentys
MIAMI LAKES, Fla., Jan. 09, 2018 (GLOBE NEWSWIRE) -- Regentys (formerly Asana Medical, Inc.) (the “Company”), a regenerative medicine company developing a novel treatment for Ulcerative Colitis...
Thetis Builds Scientific Advisory Board to Guide Development of Immuno-Resolving Therapies for IBD
December 11, 2017 10:35 ET
|
Thetis Pharmaceuticals LLC
BRANFORD, Conn., Dec. 11, 2017 (GLOBE NEWSWIRE) -- Thetis Pharmaceuticals LLC (“Thetis”), a biopharmaceutical company developing oral, “immuno-resolving” therapies to treat inflammatory bowel...
Thetis Pharmaceuticals Awarded $2.3 Million Fast-Track NIH Grant to Develop Immuno-Resolving Therapy for Inflammatory Bowel Disease
November 16, 2017 12:35 ET
|
Thetis Pharmaceuticals LLC
BRANFORD, Conn., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Thetis Pharmaceuticals, a biopharmaceutical company developing “immuno-resolving” therapies for treatment of inflammatory bowel disease (IBD),...
Atlantic Healthcare develops tablet formulations of alicaforsen to treat Crohn's disease and Ulcerative Colitis
May 30, 2017 08:00 ET
|
Atlantic Healthcare plc
CAMBRIDGE, U.K., May 30, 2017 (GLOBE NEWSWIRE) -- Atlantic Healthcare plc (“Atlantic Healthcare”), an emerging trans-Atlantic pharmaceutical company with a core focus on gastrointestinal (GI)...
Jennifer Jaff Center Merges with Patient Advocate Foundation
May 02, 2016 09:14 ET
|
Patient Advocate Foundation
HAMPTON, Va., May 2, 2016 (GLOBE NEWSWIRE) -- The Jennifer Jaff Center, a respected national nonprofit for those suffering from chronic illness, has partnered with Patient Advocate Foundation to...
VG Life Sciences Announces Issuance of Patent Covering Treatment of Inflammatory Bowel Disease with Clip-Inducing Agent
January 29, 2015 09:12 ET
|
VG Life Sciences
SANTA BARBARA, Calif., Jan. 29, 2015 (GLOBE NEWSWIRE) -- VG Life Sciences, (VGLS), a biotechnology company developing therapies for autoimmune and infectious diseases, today announced the U.S. Patent...
Photo Release -- Top Global Experts Join AXIM Biotechnologies Advisory Board
November 06, 2014 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, Nov. 6, 2014 (GLOBE NEWSWIRE) -- AXIM Biotechnologies (OTC:AXIM) is setting the "green standard" in the industrial hemp industry, tapping two world-renown experts to advise on the Company's...
Early Diagnosis and Public Awareness of Crohn's and Ulcerative Colitis Critical to Patient Care
November 23, 2011 09:00 ET
|
Crohn's & Colitis Foundation of Canada (CCFC)
TORONTO, ONTARIO--(Marketwire - Nov. 23, 2011) - Imagine experiencing agonizing and debilitating pain that lasts for hours, months and even a year without a Doctor or Medical Practitioner...
Research Indicates Synthetic Compound NV-52 May Be Useful in Treatment of Inflammatory Bowel Disease
November 13, 2007 08:04 ET
|
Novogen, Limited
NEW CANAAN, CT and SYDNEY, AUSTRALIA--(Marketwire - November 13, 2007) - An article published
in a recent edition of the peer review journal Expert Opinion, Vol. 16, No.
8, reveals the compound...